Newron Pharmaceuticals (NWRN.SW)

P/S ratio at the end of 2023: 10.5

According to Newron Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -4.97. At the end of 2023 the company had a P/S ratio of 10.5.

P/S ratio history for Newron Pharmaceuticals from 2006 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	10.5	129.1%
2022	4.58	-5.53%
2021	4.85	-27.95%
2020	6.73	-54.65%
2019	14.8	-32.87%
2018	22.1	67.79%
2017	13.2	-76.3%
2016	55.6	-60.74%
2015	142	-22.44%
2014	183	305.31%
2013	45.0	430.01%
2012	8.50	177.83%
2011	3.06	-94.23%
2010	53.0	62.88%
2009	32.6	123.09%
2008	14.6	-66.81%
2007	44.0	-72.9%
2006	162

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Newron Pharmaceuticals (NWRN.SW)